“A New Antioxidant Nutraceutical Compound Is Able to Reduce the Level of Prostate Pro-Inflammatory Mediators: Results from a Phase III, Placebo Controlled Trial”. 2026. Archivio Italiano Di Urologia E Andrologia, November. https://doi.org/10.4081/aiua.2026.14712.